We investigated the nasopharyngeal carriage of Streptococcus pneumoniae and Staphylococcus aureus in 355 children hospitalized with severe pneumonia. Of the children, 239 (67.3%) were human immunodeficiency virus (HIV)-1 positive; 169 (47.6%) carried S. pneumoniae, 91 (25.6%) carried S. aureus, and 33 (9.3%) carried both. S. pneumoniae carriage was not related to HIV-1 status. The HIV-1-positive children had a significantly higher rate of S. aureus carriage than did the HIV-1-negative children (31.4% vs. 13.8%;
anism of the relationship is unknown, but it has been suggested that production of hydrogen peroxide by S. pneumoniae inhibits S. aureus colonization [3] .
We have analyzed data from a prospective study of children hospitalized with World Health Organization (WHO)-defined severe pneumonia in Durban, South Africa. The subjects differed from those of the previous 2 studies in that they were black African; most of them lived in poor, overcrowded housing; and 67.3% were infected with HIV-1. The children in the Dutch study were healthy and were participating in a national meningococcal vaccine campaign [1] . The children in the Israeli study were recruited through primary-care clinics in central Israel; 80% were attending a clinic because of a respiratory infection [2] .
The primary aim of the overall study was to determine the response rates of children hospitalized with severe pneumonia to WHO-recommended antimicrobial therapy. These results are to be published separately. One of the secondary aims of the study was to describe the carriage of organisms in the nasopharynx in relation to HIV-1 status. The objectives of the present analyses were (1) to identify risk factors for nasopharyngeal carriage of S. pneumoniae and S. aureus; (2) to investigate any association between carriage of the 2 organisms; and (3) to determine whether HIV-1 status alters the rate of carriage in South African children admitted to the hospital with severe pneumonia.
Subjects, materials, and methods. Between January 2001 and December 2002, 355 children were admitted to King Edward VIII Hospital (Durban, South Africa) with WHO-defined severe pneumonia (cough or difficulty breathing, tachypnea, and chest indrawing). Immediately after study inclusion, while the child was still in the admission unit and before the first dose of antimicrobials had been administered, a flexible swab (Transwab; Medical Wire and Equipment) was inserted into the anterior nares, gently rubbed on the posterior nasopharyngeal wall, and removed. The swab was transferred to the laboratory in Amies transport medium at room temperature. Nasopharyngeal swabs were streaked onto blood agar, colistin nalidixic acid, and mannitol salt agar plates and incubated aerobically at 37ЊC in 5% CO 2 -enriched air. Colonies mor-phologically suggestive of S. pneumoniae and S. aureus were isolated and identified using optochin susceptibility and tube coagulase testing, respectively. Pneumococci were transferred to the Pneumococcal Diseases Research Unit (Medical Research Council/National Health Laboratory Service, University of Witwatersrand; Johannesburg, South Africa) on Dorset egg medium. Serotyping was performed by the Quellung method, using antisera from the Statens Seruminstitut, Copenhagen. Vaccine types were defined as those serotypes included in the 7-valent conjugate vaccine (Prevenar; Wyeth Vaccines) as well as the crossreactive types (i.e., 4, 6, 9, 14, 18, 19, and 23). Methicillin-resistant S. aureus (MRSA) was identified using 1-mg oxacillin discs on Mueller-Hinton agar supplemented with 4% NaCl.
HIV-1 infection was diagnosed by anonymous linked ELISA antibody testing (Vironostika IMPVD; bioMérieux) followed by determination of HIV-1 RNA load (NucliSens HIV-1 assay; bioMérieux). For those children who were positive for HIV-1 by ELISA and had an HIV-1 RNA load of !10,000 copies, a confirmatory HIV-1 DNA polymerase chain reaction assay (Molecular Diagnostic Services) was performed. This assay detects all HIV-1 strains. There were no discordant HIV-1 DNA and RNA test results.
As part of the study-consent process, the mothers of the children received pretest HIV counseling. They were informed that neither the study team nor their provincial doctors would know the result and were encouraged to consent to a provincial HIV test. Posttest counseling was provided with this result. The present study was approved by the ethics committees of the Nelson R. Mandela School of Medicine, University of KwaZuluNatal, and the Institute of Child Health, University College London. Written, informed consent was obtained from the mothers of all of the study children.
Data were analyzed using SPSS for Windows (version 12.0.1; SPSS). Odds ratios (ORs) were calculated to assess risk factors for carriage of each organism, including age 13 months, sex, household size, number of children living in the house, number of persons sleeping in the same room as the child, previous hospital admission, history of antibiotic treatment during the current illness (maternal history), urinary antimicrobial activity, passive smoking, family history of respiratory disease during the previous 2 weeks, family history of tuberculosis (TB) during the previous 2 years, up-to-date immunizations, and HIV-1 status. A multivariate logistic regression analysis with stepwise backward elimination was performed separately for each pathogen. The Ϫ2 log likelihood test, the Nagelkerke R 2 test, and the Hosmer-Lemeshow test were used to assess goodness of fit. The multivariate analyses were then repeated for HIV-1-positive and HIV-1-negative children separately.
Results. A total of 355 children 1-59.4 months old (median, 4.3 months) were enrolled; 195 (54.9%) were male, and 353 (99.4%) were black (mostly Zulu). The median household size was 5.5 persons, with a median of 2 children living in the house and a median of 3 persons sleeping in the same room as the child. One hundred fifty-three children (43.1%) were exposed to household cigarette smoke (passive smoking); 91 (25.6%) had a previous hospital admission; 145 (40.8%) had a history of antibiotic treatment during the current illness; 71 (20.0%) had a family history of respiratory disease during the previous 2 weeks; 123 (34.6%) had a family history of TB during the previous 2 years; and 239 (67.3%) were HIV-1 positive. Eighty (39.0%) of 205 samples obtained for assessment of urinary antimicrobial activity were positive.
The HIV-1-positive children were, on average, older than the HIV-1-negative children (mean, 11.4 vs. A causative organism was identified for 65.1% of the children: 52 (14.6%) had culture-proven TB, 33 (9.3%) had Pneumocystis pneumonia, and 116 (32.6%) had a viral etiology. Seventy-six children (21.4%) had an organism identified from their admission blood culture; 26 (7.3%) had S. pneumoniae bacteremia, and 13 (3.7%) had S. aureus bacteremia.
S. pneumoniae was isolated from 169 children (47.6%) ( Serotyping results were available for 157 of the 169 children carrying S. pneumoniae; 9 had 2 different serotypes isolated on admission to the hospital (5 were HIV-1 positive). Figure 1 details the serotype distribution. The most common serotypes were 6A (12.8%), 6B (13.4%), 19A (12.2%), 19F (14.7%), and 23F (14.1%). Of the serotypes identified, 129 (82%) were vaccine types. Thirty-nine (75%) of the S. pneumoniae isolates from the HIV-1-negative children and 87 (85%) of the S. pneumoniae isolates from the HIV-1-positive children were vaccine types.
The frequency of S. pneumoniae bacteremia was higher in S. pneumoniae carriers than in noncarriers (19/169 [11.2%] ). Neither HIV-1 status nor urinary an-P p .007 timicrobial activity altered this relationship. ). Previous hospital admis-P p .126 sion was associated only with an increased rate of S. aureus carriage in the HIV-1-negative children, and a family history of TB during the previous 2 years was associated only with an increased rate of S. aureus carriage in the HIV-1-positive children.
S. aureus was isolated from 6 (21.4%) of 28 children carrying nonvaccine serotypes and from 24 (18.6%) of 129 children carrying vaccine serotypes. There was no difference between the carriage rates of S. aureus, vaccine pneumococcal serotypes, and nonvaccine pneumococcal serotypes, although the relationship was significant by the x 2 test for trend ( ). Among the HIV-P p .11 1-positive children, there was no association between either trimethoprim-sulfamethoxazole prophylaxis or lymphocytic interstitial pneumonitis and S. pneumoniae, S. aureus, or dual carriage, and there was no association between HIV-1 RNA load and carriage of either organism. There was also no association between HIV-1 RNA load and cocolonization.
The HIV- ) were P p .001 the only predictors of S. pneumoniae carriage; S. aureus carriage was no longer inversely related to it. S. pneumoniae carriage was also not negatively associated with S. aureus carriage.
Discussion. Our data confirm the inverse relationship between the nasopharyngeal carriage of S. pneumoniae and S. aureus in HIV-negative children [1, 2] . The South African HIVnegative children in the present study had rates of S. pneumoniae, S. aureus, and dual carriage that were similar to those of Israeli children [2] ; however, the association between the nasopharyngeal carriage of S. pneumoniae and S. aureus was absent in HIV-positive children, resulting in a higher dual carriage rate of 26.3%. HIV infection is known to be a risk factor for S. aureus colonization [4, 5] and, given that S. aureus colonization is a risk factor for S. aureus septicemia, the lack of a negative association may partly explain the increased rates of S. aureus disease seen in HIV-infected patients [4, 6] .
In microbiological interference, pathogens generate a niche in the host that suppresses the colonization of other microorganisms [3] . Little is known about the exact mechanism of the interaction. However, adhesion to mucosal receptors, host immunity, and exposure have been implicated in colonization [7] . HIV-infected children have reduced mucosal immunity and are known to have reduced quantitative antibody responses to pneumococcal conjugate vaccination [8] . They are also at increased risk of hospital admission and have more contacts with family members who have been hospitalized. It is possible that HIV infection results in less immunological pressure, leading to less competition between the 2 organisms combined with increased exposure to respiratory pathogens, including S. aureus.
There are several limitations to the present study. First, the study children had severe pneumonia. It is possible that the negative relationship between the rates of carriage of S. pneumoniae and S. aureus remains in HIV-positive children without pneumonia. However, although S. pneumoniae carriage was associated with an increased rate of S. pneumoniae bacteremia, S. aureus carriage was not associated with an increased rate of S. aureus bacteremia. HIV-1 status had no effect on the relationship for either organism. Because (1) all of the study children had severe pneumonia irrespective of their HIV-1 status and (2) the association between carriage and bacteremia was not associated with HIV-1 status, it is unlikely that the lack of association seen in our HIV-1-infected children would be different in a population without severe pneumonia. In addition, 80% of the children in the Israeli study had a respiratory infection [2] .
Second, the present study was cross-sectional. A longitudinal study would be required to determine a causal relationship between carriage of S. pneumoniae and S. aureus as well as the impact of HIV status. Finally, the interaction between carriage of S. pneumoniae and S. aureus is likely to be complex, and some possible confounding factors were not measured here, including hospitalization of other family members, length of time since last hospital admission, and day-care attendance (which is unusual in this population).
Our data suggest that the negative association with S. pneumoniae carriage is strongest for MRSA. No HIV-1-negative children carrying S. pneumoniae were coinfected with MRSA. There have been increasing reports of community-acquired MRSA disease recently [9, 10] , and there was an increase in the rate of nasal carriage of MRSA in the United States from 2002 to 2004 [11] . There have also been reports that children given the pneumococcal conjugate vaccine have higher rates of S. aureus otitis media than do children who have not received the vaccine [12] . Any possible increase in the frequency of MRSA disease due to pneumococcal conjugate vaccination needs to be further investigated.
In the present study, girls had higher rates of S. pneumoniae carriage than boys; however, this relationship was only statistically significant in infants р3 months old. The nasal mucosa is estrogen sensitive [13, 14] , and infant girls р3 months old could still be responding to their intrauterine environment.
Our study confirms the inverse relationship between the nasopharyngeal carriage of S. pneumoniae and S. aureus in HIV- negative children. However, we found this relationship to be absent in HIV-positive children. Further research is required, both on the role played by the host in bacterial interaction and on the possible implications of widespread pneumococcal vaccination.
